Find Academic Supervisors

Claudia AllemaniView profile

Professor

• Cancer Epidemiology
• Global Public Health
• Survival Analysis
• +3 more

Claudia Allemani is Professor of Global Public Health at the London School of Hygiene & Tropical Medicine (LSHTM), where she leads the Cancer Survival Group within the Department of Non-Communicable Disease Epidemiology in the Faculty of Epidemiology and Population Health. With over 20 years of experience in cancer epidemiology, she serves as co-Principal Investigator for the global CONCORD cancer surveillance program and Principal Investigator for the ERC-funded VENUSCANCER project studying worldwide inequalities in cancer survival. Her educational background spans applied mathematics to public health, with degrees including an MSc in Mathematics from the University of Turin (1996), MSc in Statistical and Informatic Methods from the University of Milan (1998), a PhD equivalent in Medical Statistics (2001), and a PhD in Public Health and Education (2006), all from Italian institutions. Professor Allemani's research focuses on international comparisons of cancer survival trends, high-resolution studies on patterns of care, and estimation of avoidable premature deaths with direct impact on cancer policy. Her work encompasses multiple cancer types across more than 70 countries, examining how healthcare systems, socioeconomic factors, and policy interventions affect cancer outcomes globally. She has pioneered methodologies for population-based cancer survival analysis that have become standard in the field. Her extensive publication record demonstrates consistent focus on global cancer surveillance, with particular attention to breast, cervical, and ovarian cancers, as well as pediatric malignancies. The research shows clear evolution from European-focused studies (EUROCARE) to truly global population-based analyses (CONCORD), reflecting growing recognition of cancer as a worldwide health challenge requiring international comparative approaches. Fellow of the Higher Education Academy (2012) Honorary Member of the UK Faculty of Public Health (2014) UK Faculty of Public Health's inaugural Global Public Health Award (2016) European Research Council Consolidator grant recipient (2017) Member of The Lancet Oncology International Advisory Board (2021-2024) Co-Chair of the CONCORD-Lancet Global Commission on Cancer Professor Allemani actively supervises PhD students and teaches across multiple MSc programs at LSHTM, particularly in epidemiology and medical statistics. Her grant portfolio includes major funding from the European Research Council, Cancer Research UK, CDC, WHO, and other international bodies supporting the CONCORD program's expansion to include 22 adult cancers and all childhood cancers diagnosed from 2000-2019 across 70+ countries. She leads a dedicated team of five researchers in the Cancer Survival Group, collaborating with major international health organizations including the Organisation for Economic Co-operation and Development, US Centers for Disease Control and Prevention, Institute for Health Metrics and Evaluation, WHO, International Atomic Energy Agency, and numerous national cancer institutes to translate survival data into actionable cancer control policies worldwide.

Soyeon AhnView profile

Professor

• Health Communication
• Educational Assessment
• Psychometrics
• +3 more

Soyeon Ahn is a full-time Professor in the Department of Education and Psychological Studies at the University of Miami's School of Education and Human Development. Her academic profile demonstrates active research leadership in health communication, educational assessment, and psychometrics, with recent publications spanning 2024-2025. Contact details include email s.ahn@miami.edu, phone (305)284-2929, and ORCiD 0000-0003-2581-306X. Research interests focus on Health Belief Model applications in social media health campaigns, fairness evaluation of high-stakes educational exams, and eHealth interventions for obesity management. She investigates how content creator characteristics (e.g., race, occupation) affect user engagement with health messages, examines psychometric validation of assessment tools via Rasch modeling, and explores generative AI's pedagogical impact. Her work integrates intersectionality frameworks to address health disparities in clinical settings. Recent publications reveal strong interdisciplinary trends connecting public health, education, and technology. Key themes include methodological rigor in meta-analyses of occupational cancer studies, social media's role in vaccine behavior change, and AI literacy training for educators. Her findings consistently emphasize practical implications: optimizing health messaging through HBM constructs, addressing test bias in educational equity, and leveraging technology for behavior intervention. The 2024-2025 output shows increasing focus on real-world application of measurement theory.

Angela K. OdleView profile

Assistant Professor

• Molecular Neuroendocrinology
• Development of the Pituitary
• Neuroendocrine Control of the Female Reproductive Axis

Angela K. Odle is an Assistant Professor in the Department of Neuroscience at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. Her roles include serving as a Basic Science Advisor in the College of Medicine Academic House Program, a member of the Graduate Council, and Assistant Track Director for the Graduate Program in Biomedical Sciences. Education: Ph.D. and Postdoctoral Training at UAMS. Dr. Odle's research focuses on molecular neuroendocrinology, particularly the neuroendocrine control of the female reproductive axis and the role of Musashi proteins in regulating mRNA translation. Her work explores how leptin modulates GnRHR expression and metabolic functions in mouse models. Her publications highlight recent advancements in neuroendocrine mechanisms, including Musashi-mediated translational control during the estrous cycle, leptin's influence on GnRHR mRNA binding, and comparative studies on adipocyte versus somatotrope leptin signaling. Key Roles: Basic Science Advisor, Academic House Program Member, Graduate Council Assistant Track Director, Biomedical Sciences Graduate Program Researcher in Neuroendocrinology

• Biochemistry
• Molecular Biology
• Tissue Engineering
• +9 more

Marta Monjo Cabrer is a Full Professor in the Department of Biochemistry and Molecular Biology at the Faculty of Fundamental Biology and Health Sciences, University of the Balearic Islands (UIB). She co-leads the Cell Therapy and Tissue Engineering (TERCIT) research group, affiliated with UIB, IUNICS, and the Balearic Islands Health Research Institute (IdISBa). She also coordinates the PhD in Translational Research in Public Health and Highly Prevalent Diseases (TISP) and serves on key scientific committees including the Internal Scientific Committee (CCI) and Innovation Commission (CI) of IdISBa. University: University of the Balearic Islands (UIB) Faculty: Faculty of Fundamental Biology and Health Sciences Department: Biochemistry and Molecular Biology Research Group: TERCIT (Cell Therapy and Tissue Engineering) Institutional Affiliations: IUNICS, IdISBa, BIOIB (former) Education: Bachelor in Biology, University of the Balearic Islands (1998) Bachelor in Biochemistry, University of the Balearic Islands (1999) PhD in Biochemistry and Molecular Biology, UIB (2004) Predoctoral Fellowship, UIB (2000–2003) Visiting Researcher, Institute for Nutrition Research, University of Oslo (2001–2002) Postdoctoral Researcher, Department of Biomaterials, University of Oslo (2004–2008) Her research focuses on biochemistry, molecular biology, tissue engineering, regenerative medicine, biomaterials, drug delivery systems, and therapeutic extracellular vesicles . She has extensive experience in technology transfer and the development of dental implants and specialized medical products. Her academic trajectory includes roles as Associate Professor (2007–2008), Ramón y Cajal Researcher (2009–2013), Contracted Doctoral Lecturer (2014–2017), Senior Lecturer (2017–2022), and Full Professor (current). She has supervised numerous predoctoral and postdoctoral researchers and teaches courses such as General Biochemistry Laboratory, Biomaterials, and Master's thesis projects. The analysis of her scholarly output reveals a strong emphasis on translational research, with publications and projects centered on developing clinical applications of biomaterials and cell-based therapies. Her work bridges laboratory innovation with real-world medical solutions, particularly in dentistry and regenerative medicine. She has contributed to over 90 articles, 5 patents, and more than 100 conference presentations, reflecting a consistent and impactful research trajectory. Scientific Awards and Recognitions: Several entrepreneurship awards 4 teaching quinquenia (five-year teaching periods) 3 research sexenia (six-year research periods) 1 transfer quinquenium (knowledge transfer) CAIB salary supplements for teaching, research excellence, and knowledge transfer Marta Monjo actively supervises predoctoral and postdoctoral researchers and has participated in 27 research projects (13 as principal investigator) and over 30 industry contracts. She played a key role in founding two biotechnology companies and was a member of the executive committee of the Biotechnology and Biomedical Cluster of the Balearic Islands (BIOIB) until 2013. Her leadership extends to academic governance and innovation strategy through her roles in IdISBa and interdisciplinary research coordination. Laboratories and Research Teams: Principal Investigator, Cell Therapy and Tissue Engineering (TERCIT) Group, UIB Co-leader with Dr. Joana Mª Ramis Affiliated with IUNICS and IdISBa Active in technology transfer and clinical translation of biomaterials

• Cardiovascular Disease Epidemiology
• Global Health
• Public Health Policy
• +5 more

Goodarz Danaei is the Bernard Lown Professor of Cardiovascular Health at the Harvard T.H. Chan School of Public Health, affiliated with the Department of Global Health and Population and the Department of Epidemiology. He holds a medical degree from Tehran University and advanced degrees in epidemiology from Harvard. His research focuses on quantifying population-level impacts of risk factors and interventions on cardiovascular disease, especially in low- and middle-income countries. He leads global consortia analyzing cardiometabolic risk factors (NCD Risk Collaboration) and developed the GLOBO RISK cardiovascular prediction model used worldwide. His methodological work applies causal inference techniques like Marginal Structural Models and parametric G-formula to observational health data. He directs the Bernard Lown Scholars Program training global health leaders in cardiovascular disease prevention. Recent grants include NIH-funded studies on diabetes disparities and CVD training programs. Key achievements include: Developed first country-level CVD risk prediction tool Validated WHO risk models for Middle East Advanced causal inference methods for chronic disease research Trained over 100 mid-career professionals through Lown Scholars Research focuses on applying epidemiological methods to: Health disparities analysis Clinical preventive strategies Global CVD prevention policies Mediation analysis in chronic disease pathways Recent work emphasizes: Aspirin self-administration for acute cardiac events Statin therapy risks/benefits in aging populations Cardiometabolic risk modeling in diverse populations

Kerry Stephen SeilerView profile

Professor

• Exercise Physiology
• Endurance Training
• Polarized Training Models
• +3 more

Kerry Stephen Seiler is a Professor at the University of Agder in Norway, specifically within the Department of Sport Science and Physical Education under the Faculty of Health and Sport. He has been actively involved in research and consultation since the late 1990s, including roles as a research consultant for the Sorlandet Regional Hospital and the Norwegian Olympic Federation. Masters in Exercise Science (1987), University of Arkansas PhD in Kinesiology (Exercise Physiology and Biochemistry, 1995), University of Texas His research focuses on Exercise Physiology , particularly the interaction between brain and body during physical exertion and how cardiovascular systems adapt to training . He developed the SPADE research group (Sports Performance and Athlete Development Environments) and is a leading voice in 80/20 endurance training principles. Recent publications emphasize training intensity distribution , low-intensity endurance strategies , and polarized training models . His work often intersects with practical applications in professional cycling and endurance sports. Fellow, European College of Sport Science Fellow, American College of Sports Medicine He has contributed extensively to media platforms like Fast Talk Laboratories , The Roadman Cycling Podcast , and Podcast Feel Better Live More , discussing topics ranging from Zone 2 training to exercise as a longevity tool .

Tyler BoldView profile

Associate Professor

• Infectious Diseases
• Immunology
• Microbiology
• +3 more

Tyler Bold, MD, PhD serves as Associate Professor in the Division of Infectious Diseases and International Medicine within the Department of Medicine at the University of Minnesota Medical School. He concurrently holds faculty appointments in the Microbiology, Immunology and Cancer Biology (MICaB) Ph.D. Graduate Program and the Department of Medicine, establishing a multidisciplinary research presence spanning infectious disease pathogenesis, immunology, and host-pathogen interactions. His research program integrates clinical infectious disease expertise with fundamental immunological investigation, focusing on tuberculosis host-directed immunotherapy, SARS-CoV-2 pathogenesis mechanisms, and macrophage biology in atherosclerosis. Key interests include T cell costimulation in granulomatous diseases, viral-microbiome interactions during respiratory infections, and diagnostic innovations for resource-limited settings. His work bridges basic science discovery with translational clinical applications, particularly in immunocompromised populations and complex infectious syndromes. Analysis of his 15 most recent publications reveals dominant research trajectories in tuberculosis immunology (40% of articles), SARS-CoV-2 pathogenesis and therapeutics (35%), and atherosclerosis immunometabolism (15%), with emerging work on fungal infections in hematologic malignancies. The publications demonstrate consistent use of advanced techniques including single-cell resolution analysis, structural biology, and randomized clinical trials, reflecting both mechanistic depth and clinical relevance across infectious disease subspecialties.

Adrienne M. AntonsonView profile

Assistant Professor

• Neuroimmunology
• Neurodevelopment
• Microglia
• +7 more

Adrienne M. Antonson is an Assistant Professor in the Department of Animal Sciences at the University of Illinois Urbana-Champaign, affiliated with the College of Liberal Arts & Sciences Neuroscience Program. She leads the Antonson Developmental Neuroimmunology Lab, focusing on immunology, microbiology, and developmental neuroscience. Education: PhD in Immunophysiology and Behavior (University of Illinois Urbana-Champaign, 2018), Postdoctoral Fellow at Ohio State University (2018-2021) Affiliations: Microbial Systems Initiative, Carl R. Woese Institute for Genomic Biology (Environmental Impact on Reproductive Health Theme), Interdisciplinary Environmental Toxicology Program Her research investigates how prenatal maternal immune activation—via viral infections or stress—alters fetal microglial function and neurodevelopmental outcomes. Using translational animal models, she examines inflammatory pathways linking maternal insults to behavioral abnormalities and mental health disorders in offspring. Recent publications reveal critical insights into influenza A virus impacts on maternal-fetal immunity, epigenetic disruptions in hypothalamic development, and microbiome-mediated neuroinflammatory mechanisms. Her work emphasizes the maternal-fetal interface as a key regulator of neurodevelopmental trajectories. Contact: aantnsn2@illinois.edu , Edward R. Madigan Laboratory, 1201 W Gregory Drive, Urbana, IL 61801

Shelley L. BergerView profile

Professor

• Epigenetics
• Chromatin structure and function
• Histone modifications
• +7 more

Shelley L. Berger is the Daniel S. Och University Professor at the University of Pennsylvania, holding a "Penn Integrates Knowledge" Presidential Appointment. She serves as Director of the Epigenetics Institute at the Perelman School of Medicine and is Co-Director of the Tumor Biology Program at the Abramson Cancer Center. Her academic appointments span multiple departments including Cell and Developmental Biology, Biology, and Genetics. Dr. Berger earned her B.S. in Biology from the University of Michigan, Ann Arbor in 1982, followed by a Ph.D. in Cell & Molecular Biology from the same institution in 1987. Her distinguished career has led to her current position as a University Professor, one of the highest academic honors at the University of Pennsylvania. Dr. Berger's research focuses on epigenetics and chromatin structure/function in genomic regulation, with particular interest in post-translational modifications of histones and transcription factors. Her laboratory investigates how DNA-packaging structures are manipulated during genomic processes, with applications to understanding cancer, neurodegeneration, and other diseases. Her work spans multiple biological contexts including: Chromatin regulation of transcription Neuroepigenetics and memory formation Behavioral epigenetics in social insects Chromatin regulation in aging and senescence Cancer epigenetics and tumor suppressor mechanisms Analysis of Dr. Berger's recent publications reveals a strong focus on the intersection of epigenetics with aging, cancer, and neurobiology. Her work demonstrates how histone modifications and chromatin remodeling influence cellular senescence, with implications for age-related diseases including Alzheimer's. She has also pioneered research on epigenetic mechanisms in social behavior using ant models, and in T cell exhaustion relevant to cancer immunotherapy. A unifying theme across her publications is the role of specific histone modifications and chromatin regulators in controlling gene expression programs in diverse biological contexts. Dr. Berger has received numerous honors including her appointment as a Daniel S. Och University Professor and a "Penn Integrates Knowledge" Presidential Appointment, recognizing her exceptional interdisciplinary contributions to science. These prestigious appointments reflect her significant impact on the fields of epigenetics and chromatin biology. Dr. Berger mentors a vibrant research team consisting of multiple postdoctoral researchers, graduate students, and research specialists. Her laboratory, part of the Epigenetics Institute at Penn, investigates fundamental mechanisms of chromatin regulation with implications for human health and disease. Current research directions include exploring how epigenetic mechanisms control aging processes, cancer development, and social behavior in model organisms. Dr. Berger collaborates extensively with other leading researchers, including Carl June (pioneer of CAR T cell therapy) and John Wherry (expert in T cell exhaustion), to translate basic epigenetic discoveries into potential therapeutic applications. The Berger Lab operates within the Smilow Center for Translational Research at the University of Pennsylvania. The lab employs a multidisciplinary approach combining molecular biology, genomics, bioinformatics, and model organism studies to investigate chromatin regulation. Current research foci include epigenetic mechanisms in aging and senescence, cancer epigenetics, neuroepigenetics, and behavioral epigenetics in social insects.

• Cancer Biology
• Pathobiology
• FGF Signalling
• +12 more

Dr. Athina-Myrto Chioni is a Senior Lecturer in Pathobiology and Cancer Biology at Kingston University, within the Department of Biomolecular Sciences, School of Life Sciences, Pharmacy and Chemistry. She holds a PhD from Imperial College London and conducted postdoctoral research at Barts and The London School of Medicine and Dentistry, Queen Mary University of London. She joined Kingston University in 2014 and was promoted to Senior Lecturer in 2016, also serving as Deputy Course Director for the BSc Biomedical Sciences program from 2016 to 2021. Education: BSc (Hons) Biology, Imperial College London (1998–2001) MSc Molecular Medicine, Imperial College London (2001–2002) PhD Cell and Molecular Biology, Imperial College London (2003–2006) Postdoctoral Research Fellow, Queen Mary University of London (2006–2014) Her research focuses on fibroblast growth factor (FGF/FGFR) signaling in cancer , particularly its role in tumor progression, drug resistance, and metastasis. She investigates the nuclear translocation of cleaved FGFR in breast, pancreatic, and cervical cancers, a novel mechanism with potential therapeutic implications. Her work also explores organotypic models to study tumor-stroma interactions and signaling pathways like ERK. She has made significant contributions to understanding how FGFR signaling drives invasive behavior in cancer cells. Her recent publications (2021–2025) emphasize FGFR inhibitor resistance in cervical cancer , KISS1R antagonism for restoring drug sensitivity in triple-negative breast cancer, and the dysregulation of signaling pathways in drug resistance . These works reflect a strong trend toward understanding resistance mechanisms and identifying novel therapeutic targets in gynecological and breast cancers. Scientific Awards: Imperial College Marshall Scholarship A.G. Leventis Foundation Studentship Papanikolau First Prize Award First Prize, Sylvia Lawler Meeting (Royal Society of Medicine) William Harvey Day Poster Awards (2008, 2011) Junk the Jargon Competition Winner (QMUL, 2011) 1st Prize, Barts and Queen Mary Science Festival (2012) Gordon Conference Poster Award (2012) Dr. Chioni has successfully supervised multiple PhD and MRes students, including Hiba-Tun-Noor Mahmood and Fazeela Ashiq to completion. She has secured competitive research grants from the Breast Cancer Campaign (awarded twice, 2009 and 2013). She serves as an External Examiner for programs at Imperial College London and the University of Hertfordshire, and for MSc programs at QMUL. She is also a Guest Editor for the International Journal of Molecular Sciences and Review Editor for Frontiers in Cell and Developmental Biology . She is a member of the Faculty EDI Action Group and the EACR Ambassador program. She is affiliated with several professional bodies including Fellow of the Royal Society of Biology (FRSB) , Fellow of the Institute of Biomedical Sciences (FIBMS) , and member of the European Association of Cancer Research (EACR) and Genetics Society . Her expertise includes confocal microscopy, 3D organotypic cultures, immunocytochemistry, and functional cancer biology assays.

• Epidemiology
• HIV
• Sexually Transmitted Infections
• +4 more

Lei Zhang is a Professor (Research) and Head of the Artificial Intelligence and Modelling in Epidemiology Program at the School of Translational Medicine, Monash University, Australia. He holds adjunct roles at institutions like Tsinghua University and is a consultant to the WHO Western Pacific Region. His expertise spans HIV/STI epidemiology, mathematical modelling, and AI-driven healthcare solutions. Education: Bachelor of Advanced Science in Mathematics (University of Sydney, 2001) Master of Science in Applied Mathematics (University of Sydney, 2003) PhD in Medicine (UNSW, 2006) Master of Public Health (Hamburg University of Applied Sciences, 2009) Research Interests: Prof. Zhang focuses on cross-disciplinary research in HIV/STI epidemiology, AI applications for disease modeling and diagnostics, health economics, and global health policy. His work integrates mathematical models with clinical data to optimize interventions and inform policy. Key Projects: HOPE: Optimizing HIV Pre-Exposure Prophylaxis (PrEP) in East Asia WHO Collaborations: Supporting global STI programs and policy development China-Australia Joint Research Center for Infectious Diseases Awards: 2021 ASRHA Innovation Award for HIV/STI research contributions Advising & Grants: Supervised 21 students (6 PhD, 15 MSc) and currently co-supervises 24 students (11 PhD, 13 MSc). Leader of 5+ major research grants, including NHMRC-funded projects on STI control and diabetes research. Labs/Teams: Leads the AI & Modelling in Epidemiology Program and collaborates with global networks like UNAIDS, the World Bank, and ministries of health across the Western Pacific region.

• Environmental Toxicology
• Physiological Effects of Contaminants
• Neurobehavioral Toxicology
• +3 more

Som Niyogi is an Associate Professor at the University of Saskatchewan's Toxicology Program within the College of Arts & Science. He also serves as Adjunct Faculty in the Department of Biology at York University, Toronto. His research focuses on the physiological and neurobehavioral effects of environmental contaminants in aquatic organisms, with expertise in metal bioavailability, ecological risk assessment, and transgenerational toxicity. Dr. Niyogi has been recognized with the 2023 College of Arts & Science Distinguished Scholar RSAW Award. His academic roles include teaching courses such as Environmental Toxicology and Physiological Toxicology . Current research integrates organismic physiology, behavioral ecology, and molecular biology to study contaminant impacts on aquatic species. Notable projects investigate arsenic's effects on zebrafish development and the neurobehavioral consequences of microplastics and bisphenol compounds. Dr. Niyogi has supervised over 40 graduate and undergraduate students, many of whom continue in academic or industry roles. His lab collaborates on biomonitoring of Arctic metal pollution and epigenetic mechanisms of transgenerational toxicity. Key funding sources include grants addressing industrial metal pollution and air quality impacts on human health. Publications span over 200 peer-reviewed articles, focusing on metal toxicity, neurobehavioral effects, and ecological risk assessment. Recent work includes studies on PFAS neurotoxicity and selenium's role in arsenic toxicity mitigation.

• Physical Activity
• Fall Prevention
• Healthy Ageing
• +3 more

Dr Juliana Souza de Oliveira is a Postdoctoral Research Fellow at the Institute for Musculoskeletal Health , a partnership between the University of Sydney and Sydney Local Health District. She holds an Adjunct Senior Lecturer position at the Sydney School of Public Health , Faculty of Medicine and Health. Her research focuses on physical activity interventions to promote healthy ageing and prevent falls in older populations, particularly through yoga and digital health (teleyoga) programs. Primary Affiliation: University of Sydney Sub-Affiliation: Sydney School of Public Health Research Partners: Sydney Local Health District, WHO, NHMRC Research Themes include fall prevention , healthy ageing , digital health interventions , and physical activity promotion . Her work spans clinical trials, systematic reviews, and meta-analyses, with a focus on community-dwelling older adults. Recent Publications (2024-2015) address topics such as fall risk factors , yoga-based interventions , sarcopenia in chronic kidney disease , cost-effectiveness of exercise programs , and teleyoga adoption during pandemics . These studies employ methodologies like randomised controlled trials , systematic reviews , and realist evaluations . Scientific Awards and Grants include funding from the Physiotherapy Research Foundation , NHMRC , and AHRA Women's Health Research Network . Her work also intersects with organisations like the Australian Association of Gerontology and International Society of Behavioral Nutrition & Physical Activity (ISBNPA) . Advisory and Collaborative Efforts extend to Charlotte KILMARTIN and Ima STRKLJEVIC , with whom she explores inpatient fall reduction and physiotherapist-led activity promotion . She collaborates extensively on NHMRC-funded trials and WHO guideline development .

• Sarcoma Immunotherapy
• Osseointegration
• Limb Salvage
• +4 more

Dr. Rosanna Wustrack is a Professor of Orthopaedic Surgery at the University of California, San Francisco (UCSF) School of Medicine, where she serves as the Chief of Orthopedic Oncology. She specializes in the surgical diagnosis and treatment of musculoskeletal tumors and fragility fractures, with a focus on limb salvage procedures and complex reconstructive surgery. Her educational background includes a BA in Biology from Yale University (1999), an MD from Washington University School of Medicine in St. Louis (2006), residency in Orthopedic Surgery at UCSF (2012), fellowship in Musculoskeletal Oncology at Memorial Sloan Kettering Cancer Center (2013), and Advanced Training in Clinical Research from UCSF (2014). She also completed Diversity, Equity, and Inclusion Champion Training at UCSF in 2018. Dr. Wustrack's research focuses on immunotherapy for sarcomas, functional outcomes in cancer patients, osseointegration, and optimizing treatment for metastatic disease. Her work also extends to global health initiatives and addressing osteoporosis in cancer survivors. She has made significant contributions to understanding tumor immunology, developing innovative reconstructive techniques, and improving outcomes for patients with musculoskeletal tumors. Her extensive publication record demonstrates expertise across sarcoma biology, orthopedic oncology, and innovative reconstructive techniques. The articles reveal a strong emphasis on translational research, with particular focus on sarcoma immunology, osseointegration technology, and outcomes research in musculoskeletal oncology. Her work bridges basic science with clinical applications, particularly in developing novel approaches to sarcoma treatment and improving prosthetic integration. UCSF Department of Orthopedic Surgery 2012 Mauer Chief Resident of the Year UCSF Department of Orthopedic Surgery 2016 James O. Johnston Resident Teaching Award UCSF Academy of Medical Educators 2018 Excellence in Teaching Award Musculoskeletal Research Society 2019-2020 Mentored Research Award UCSF Department of Orthopedic Surgery 2020 Compassionate Physician Award UCSF Health 2020 Exceptional Physician Award Dr. Wustrack serves as Principal Investigator on the Musculoskeletal Tumor Society grant "Identifying and enhancing the host immune response in adult soft tissue sarcoma" and as Co-Investigator on Department of Defense-funded research on osseointegration and neural-controlled prosthetics. Her work with the UCSF Sarcoma Center and Osseointegration Program (iCORES) demonstrates her commitment to multidisciplinary approaches to complex oncologic problems. She is actively involved in global health initiatives through the Institute for Global Health Sciences, focusing on improving surgical care access worldwide.

Olayiwola AdeolaView profile

Professor

• Swine Nutrition
• Poultry Nutrition
• Animal Nutrition
• +4 more

Olayiwola Adeola is a Professor of Animal Sciences at Purdue University's College of Agriculture. With expertise in Swine and Poultry Nutrition , he focuses on nutrient digestibility, feed ingredients, and gut microbiome research. His work bridges practical animal feeding strategies with advanced biochemical analysis. B.S., University of Ife, Nigeria M.S. and Ph.D., University of Guelph, Canada His research explores: Heat treatment effects on feed protein quality Phytase enzyme applications for mineral absorption Gut microbiome modulation through dietary supplements Energy metabolism in swine and poultry diets Non-invasive bone health assessment methods Impact of dietary fiber and antinutritional factors Recent publications highlight collaborations with researchers like Dr. Kola Ajuwon, advancing understanding of: Branched-chain amino acid interactions Maternal yeast supplementation effects Black soldier fly larvae meal applications Calcium-phosphorus balance mechanisms Dr. Adeola teaches graduate courses: ANSC 52200 - Monogastric Nutrition ANSC 62000 - Proteins and Amino Acids in Nutrition Current lab members include graduate students Abidemi Adekoya, Yuechi Fu, and Tanner Wise, with administrative support from Lab Manager Pat Jaynes.